Opsona closes Series B financing with an additional €3.3 million

Opsona Therapeutics, a 2004 spinout from Trinity College Dublin with expertise in toll-like receptors, has closed its Series B financing with the addition of the Roche Venture Fund and Enterprise Ireland to the syndicate.